Alice Ly
Direktor/Vorstandsmitglied bei Magnolia Neurosciences Corp.
Profil
Alice Ly is currently the Vice President at Alexandria Venture Investments LLC, a Board Observer at Twinstrand Biosciences, Inc., a Board Member at ApoGen Biotechnologies, Inc., the Site head at Alexandria Launchlabs, a Board Member at Proniras Corp., and a Board Member at Magnolia Neurosciences Corp.
Previously, she worked as an Associate Director at Yale University from 2010 to 2012 and as a Program Director at Harvard Innovation Labs from 2013 to 2018.
She also served as a Board Member at Rodeo Therapeutics Corp.
from 2020 to 2021.
Dr. Ly holds graduate and doctorate degrees from Yale University and an undergraduate degree from the University of California, Irvine.
Aktive Positionen von Alice Ly
| Unternehmen | Position | Beginn |
|---|---|---|
Alexandria Launchlabs
 Alexandria Launchlabs Internet Software/ServicesTechnology Services Part of Alexandria Real Estate Equities, Inc., Alexandria Launchlabs is a full-service startup platform that accelerates the growth of early-stage life science and agtech companies. The American company provides move-in-ready office/laboratory space, support resources, shared equipment and services, creative amenities, and access to startup capital through the Alexandria Seed Capital Platform. The company has implemented comprehensive COVID-19 operational measures to ensure the safety and well-being of their member companies. Alexandria Launchlabs is currently accepting applications for future members in various locations. | Corporate Officer/Principal | 01.01.2019 |
Alexandria Venture Investments LLC
 Alexandria Venture Investments LLC Investment ManagersFinance Alexandria Venture Investments LLC (Alexandria Venture) is a venture capital subsidiary of Alexandria Real Estate Equities, Inc. founded in 1996 by Joel S. Marcus. The firm is headquartered in Pasadena, California. | Private Equity Investor | 01.01.2022 |
Twinstrand Biosciences, Inc.
 Twinstrand Biosciences, Inc. Medical SpecialtiesHealth Technology Twinstrand Biosciences, Inc. develops technologies to detect ultra-rare variants. It uses technology for new generation of clinical diagnostics and tools for scientific discovery. The company was founded by Jesse Salk and Michael Schmitt in 2015 and is headquartered in Seattle, WA. | Corporate Officer/Principal | 01.01.2019 |
Magnolia Neurosciences Corp.
 Magnolia Neurosciences Corp. BiotechnologyHealth Technology Magnolia Neurosciences Corp. operates as a drug discovery and development company. The firm focuses on the creation of a novel class of neuroprotective medicines. The company was founded in 2018 and is headquartered in Seattle, WA. | Direktor/Vorstandsmitglied | 01.01.2020 |
Proniras Corp.
 Proniras Corp. BiotechnologyHealth Technology Proniras Corp. operates as a bio technology company. The company is headquartered in Seattle, WA. | Direktor/Vorstandsmitglied | 01.01.2020 |
ApoGen Biotechnologies, Inc.
 ApoGen Biotechnologies, Inc. BiotechnologyHealth Technology ApoGen Biotechnologies, Inc. operates as a biotechnology firm, which focuses on the development of therapeutics targeting drivers of cancer genomic mutation. The company was founded by John T. Santini, Jr., Reuben S. Harris, and Daniel A. Harki in 2014 and is headquartered in Seattle, WA. | Direktor/Vorstandsmitglied | 01.01.2020 |
Ehemalige bekannte Positionen von Alice Ly
| Unternehmen | Position | Ende |
|---|---|---|
Rodeo Therapeutics Corp.
 Rodeo Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Rodeo Therapeutics Corp. engages in the development of drugs. The firm develops novel small molecules therapies for the treatment of inflammatory bowel disease and the promotion of blood cell reconstitution following bone marrow transplant. It focuses on the development of small-molecule therapies that increase tissue levels of prostaglandin PGE2. The company was founded by Stanton Gerson, Sanford Markowitz, and Joseph Ready on May 15, 2017 and is headquartered in Seattle, WA. | Direktor/Vorstandsmitglied | 31.12.2021 |
Harvard Innovation Labs
 Harvard Innovation Labs Investment ManagersFinance Part of Harvard University, Harvard Innovation Labs is an alternative investment manager. The company is based in Cambridge, MA and was founded in 2011. | Private Equity Investor | 01.01.2018 |
| Yale University | Private Equity Investor | 01.01.2012 |
Ausbildung von Alice Ly
| Yale University | Doctorate Degree |
| University of California, Irvine | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Alexandria Venture Investments LLC
Alexandria Venture Investments LLC Investment ManagersFinance Alexandria Venture Investments LLC (Alexandria Venture) is a venture capital subsidiary of Alexandria Real Estate Equities, Inc. founded in 1996 by Joel S. Marcus. The firm is headquartered in Pasadena, California. | Finance |
Twinstrand Biosciences, Inc.
Twinstrand Biosciences, Inc. Medical SpecialtiesHealth Technology Twinstrand Biosciences, Inc. develops technologies to detect ultra-rare variants. It uses technology for new generation of clinical diagnostics and tools for scientific discovery. The company was founded by Jesse Salk and Michael Schmitt in 2015 and is headquartered in Seattle, WA. | Health Technology |
ApoGen Biotechnologies, Inc.
ApoGen Biotechnologies, Inc. BiotechnologyHealth Technology ApoGen Biotechnologies, Inc. operates as a biotechnology firm, which focuses on the development of therapeutics targeting drivers of cancer genomic mutation. The company was founded by John T. Santini, Jr., Reuben S. Harris, and Daniel A. Harki in 2014 and is headquartered in Seattle, WA. | Health Technology |
Alexandria Launchlabs
Alexandria Launchlabs Internet Software/ServicesTechnology Services Part of Alexandria Real Estate Equities, Inc., Alexandria Launchlabs is a full-service startup platform that accelerates the growth of early-stage life science and agtech companies. The American company provides move-in-ready office/laboratory space, support resources, shared equipment and services, creative amenities, and access to startup capital through the Alexandria Seed Capital Platform. The company has implemented comprehensive COVID-19 operational measures to ensure the safety and well-being of their member companies. Alexandria Launchlabs is currently accepting applications for future members in various locations. | Technology Services |
Rodeo Therapeutics Corp.
Rodeo Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Rodeo Therapeutics Corp. engages in the development of drugs. The firm develops novel small molecules therapies for the treatment of inflammatory bowel disease and the promotion of blood cell reconstitution following bone marrow transplant. It focuses on the development of small-molecule therapies that increase tissue levels of prostaglandin PGE2. The company was founded by Stanton Gerson, Sanford Markowitz, and Joseph Ready on May 15, 2017 and is headquartered in Seattle, WA. | Health Technology |
Proniras Corp.
Proniras Corp. BiotechnologyHealth Technology Proniras Corp. operates as a bio technology company. The company is headquartered in Seattle, WA. | Health Technology |
Harvard Innovation Labs
Harvard Innovation Labs Investment ManagersFinance Part of Harvard University, Harvard Innovation Labs is an alternative investment manager. The company is based in Cambridge, MA and was founded in 2011. | Finance |
Magnolia Neurosciences Corp.
Magnolia Neurosciences Corp. BiotechnologyHealth Technology Magnolia Neurosciences Corp. operates as a drug discovery and development company. The firm focuses on the creation of a novel class of neuroprotective medicines. The company was founded in 2018 and is headquartered in Seattle, WA. | Health Technology |